Ohcanbohtosat - Naama Rotenberg

Engineered N-TIMP2 Variant Specifically Targeting MMP-9 Exhibits Potent Anti-Glioblastoma Activity Dahkki Mark Feldman, Naama Rotenberg, Julia M. Shifman

Viečča ollesdeavstta

Improving Circulation Half-Life of Therapeutic Candidate N-TIMP2 by Unfolded Peptide Extension Dahkki Jason Shirian, Alexandra Hockla, Justyna J. Gleba, Matt Coban, Naama Rotenberg, Laura M. Strik, Aylin Alasonyalilar Demirer, Matt L. Pawlush, John A. Copland, Evette S. Radisky, Julia M. Shifman

Viečča ollesdeavstta